Filing Details
- Accession Number:
- 0001209191-18-058010
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-09 18:00:24
- Reporting Period:
- 2018-11-07
- Accepted Time:
- 2018-11-09 18:00:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1509190 | Aratana Therapeutics Inc. | PETX | Pharmaceutical Preparations (2834) | 383826477 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1578908 | Ernst Heinen | C/O Aratana Therapeutics, Inc. 11400 Tomahawk Creek Parkway, Suite 340 Leawood KS 66211 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-11-07 | 19,308 | $6.95 | 135,694 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. This sale constitutes the final sale under such trading plan.
Billionaire Hedge Funds
